AMS - Family Medicine - Endocrinology: Hyperglycemia in Type 2 Diabetes; Hyperlipidemia and CV Disease; Endocrine Disorders (Download)

Sale!
AMS - Family Medicine - Endocrinology: Hyperglycemia in Type 2 Diabetes; Hyperlipidemia and CV Disease; Endocrine Disorders (Download)

Original price was: $99.00.Current price is: $49.00.



Title: Family Medicine – Endocrinology: Hyperglycemia in Type 2 Diabetes; Hyperlipidemia and Cardiovascular Disease; Endocrine Disorders
Faculty: Michael A. Malone, M.D. and Merri Lou Pendergrass, M.D., Ph.D.

Original Release Date: July 1, 2016  Review Date: July 1, 2017  Expiration Date: July 1, 2019

TOPIC 1: Treatment of Hyperglycemia in Type 2 Diabetes.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Understand the glucose targets in T2DM.
  2. Employ the current ADA and ACE guidelines for pharmacological therapy.
  3. Develop individualized therapeutic regimens to optimize glycemic control.

TOPIC 2: Hyperlipidemia and CV Disease Prevention – A Review of the Literature and Recent AHA Guidelines.

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Create a diagnostic and treatment plan for patients based on the current evidence and AHA Guidelines.
  2. Explain similarities and differences between the most recent and previous guidelines.
  3. Identify areas of strength and weakness in the recent AHA Guidelines.
  4. Utilize the most recent cholesterol guidelines at the point of care.

TOPIC 3: Common Endocrine Disorders.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Recognize, evaluate and treat common endocrine abnormalities and employ the ALE and ATA guidelines to include:
    1. Hypoglycemia,
    2. Hypercalcemia,
    3. Low testosterone,
    4. Adrenal masses.


Total Cost: $

    Product Description

    Expiration Date: July 1, 2019

    Title: Family Medicine – Endocrinology: Hyperglycemia in Type 2 Diabetes; Hyperlipidemia and Cardiovascular Disease; Endocrine Disorders
    Faculty:     Michael A. Malone, M.D. and Merri Lou Pendergrass, M.D., Ph.D.

    Original Release Date: July 1, 2016  Review Date: July 1, 2017  Expiration Date: July 1, 2019

    TOPIC 1: Treatment of Hyperglycemia in Type 2 Diabetes.

    Upon completion of this session, the participant should be able to: GL, COMP

    1. Understand the glucose targets in T2DM.
    2. Employ the current ADA and ACE guidelines for pharmacological therapy.
    3. Develop individualized therapeutic regimens to optimize glycemic control.

    TOPIC 2: Hyperlipidemia and CV Disease Prevention – A Review of the Literature and Recent AHA Guidelines.

    Upon completion of this session, the participant should be able to: EBM, GL, COMP

    1. Create a diagnostic and treatment plan for patients based on the current evidence and AHA Guidelines.
    2. Explain similarities and differences between the most recent and previous guidelines.
    3. Identify areas of strength and weakness in the recent AHA Guidelines.
    4. Utilize the most recent cholesterol guidelines at the point of care.

    TOPIC 3: Common Endocrine Disorders.

    Upon completion of this session, the participant should be able to: GL, COMP

    1. Recognize, evaluate and treat common endocrine abnormalities and employ the ALE and ATA guidelines to include:
      1. Hypoglycemia,
      2. Hypercalcemia,
      3. Low testosterone,
      4. Adrenal masses.
    Share

    Professional Name & Certification Type are Required.

    To claim credit, you must supply your Professional Name and Certification Type on the Account Details page.

    Instructions

    » Click the Update Account Details button. On the next page provide your information and click the Save Changes button.